Terms: = Prostate cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
115 results:
1. Transcription Factors in prostate cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches.
Silva KCS; Tambwe N; Mahfouz DH; Wium M; Cacciatore S; Paccez JD; Zerbini LF
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674385
[TBL] [Abstract] [Full Text] [Related]
2. Molecular complexity of intraductal carcinoma of the prostate.
Zhu S; Xu N; Zeng H
Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
[TBL] [Abstract] [Full Text] [Related]
3. UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
Liu S; Chai T; Garcia-Marques F; Yin Q; Hsu EC; Shen M; Shaw Toland AM; Bermudez A; Hartono AB; Massey CF; Lee CS; Zheng L; Baron M; Denning CJ; Aslan M; Nguyen HM; Nolley R; Zoubeidi A; Das M; Kunder CA; Howitt BE; Soh HT; Weissman IL; Liss MA; Chin AI; Brooks JD; Corey E; Pitteri SJ; Huang J; Stoyanova T
Cell Rep Med; 2024 Feb; 5(2):101381. PubMed ID: 38244540
[TBL] [Abstract] [Full Text] [Related]
4. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-myc signaling.
Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
[TBL] [Abstract] [Full Text] [Related]
5. Vitamin K: New insights related to senescence and cancer metastasis.
Chen A; Li J; Shen N; Huang H; Hang Q
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189057. PubMed ID: 38158025
[TBL] [Abstract] [Full Text] [Related]
6. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205).
Paulraj P; Barrie E; Jackson-Cook C
Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189
[TBL] [Abstract] [Full Text] [Related]
7.
Boldrini L; Bardi M
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628609
[TBL] [Abstract] [Full Text] [Related]
8. A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Weiner AB; Liu Y; Hakansson A; Zhao X; Proudfoot JA; Ho J; Zhang JH; Li EV; Karnes RJ; Den RB; Kishan AU; Reiter RE; Hamid AA; Ross AE; Tran PT; Davicioni E; Spratt DE; Attard G; Lotan TL; Lee Kiang Chua M; Sweeney CJ; Schaeffer EM
Cancer; 2023 Jul; 129(14):2169-2178. PubMed ID: 37060201
[TBL] [Abstract] [Full Text] [Related]
9. Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis.
Alshalalfa M; Nguyen TT; Stopsack KH; Khan A; Franco I; Seldon C; Swami N; Jin W; Meiyappan K; Ton M; Venstrom JM; Dee EC; Mahal BA
Urol Oncol; 2023 Feb; 41(2):106.e17-106.e23. PubMed ID: 36400666
[TBL] [Abstract] [Full Text] [Related]
10. Hypomethylation and the Resultant Overexpressed PARM1: a Biomarker for Poor prognosis of Diffuse Large B-cell Lymphoma.
Cao B; Guo X; Wang B; Wang W; Han D; Zhang W; Zhong K
Discov Med; 2022; 33(168):27-40. PubMed ID: 36274211
[TBL] [Abstract] [Full Text] [Related]
11. Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer.
Yu J; Gao W; Gao S; Wen S; Zhao Y; Shang Z; Wang Y; Niu Y
World J Urol; 2022 Nov; 40(11):2817-2824. PubMed ID: 36205741
[TBL] [Abstract] [Full Text] [Related]
12. Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes.
Karpova Y; Johnson SJ; Bordet G; Guo D; Ghatak A; Markov DA; Tulin AV
Biomed Pharmacother; 2022 Sep; 153():113504. PubMed ID: 36076593
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced prostate cancer: Differences in Genomic Landscape Based on Race.
Zimmerman R; Bilen MA; Heath EI; Nandagopal L; Swami U; Kessel A; Jaeger E; Wesolowski S; Hernanadez EJ; Chipman J; Mack A; Ravindranathan D; Maughan BL; Nussenzveig R; Yandell M; Kohli M; Lilly MB; Sartor AO; Agarwal N; Barata PC
Oncologist; 2022 Oct; 27(10):e815-e818. PubMed ID: 36036607
[TBL] [Abstract] [Full Text] [Related]
14. Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).
Zhu S; Zhao J; Nie L; Yin W; Zhang Y; Zhao F; Ni Y; Zhang X; Wang Z; Dai J; Liu Z; Chen J; Zeng Y; Wang Z; Sun G; Liang J; Zhao X; Zhu X; Tao R; Yang J; He B; Chen N; Shen P; Zeng H
BMC Med; 2022 Jul; 20(1):237. PubMed ID: 35864546
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Potential Key Genes in prostate cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods.
Khan MM; Mohsen MT; Malik MZ; Bagabir SA; Alkhanani MF; Haque S; Serajuddin M; Bharadwaj M
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456461
[TBL] [Abstract] [Full Text] [Related]
16. RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression.
Zhou T; Wang S; Song X; Liu W; Dong F; Huo Y; Zou R; Wang C; Zhang S; Liu W; Sun G; Lin L; Zeng K; Dong X; Guo Q; Yi F; Wang Z; Li X; Jiang B; Cao L; Zhao Y
Cell Death Dis; 2022 Apr; 13(4):352. PubMed ID: 35428760
[TBL] [Abstract] [Full Text] [Related]
17. KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
Limberger T; Schlederer M; Trachtová K; Garces de Los Fayos Alonso I; Yang J; Högler S; Sternberg C; Bystry V; Oppelt J; Tichý B; Schmeidl M; Kodajova P; Jäger A; Neubauer HA; Oberhuber M; Schmalzbauer BS; Pospisilova S; Dolznig H; Wadsak W; Culig Z; Turner SD; Egger G; Lagger S; Kenner L
Mol Cancer; 2022 Mar; 21(1):89. PubMed ID: 35354467
[TBL] [Abstract] [Full Text] [Related]
18. Molecular landscape of c-myc signaling in prostate cancer: A roadmap to clinical translation.
Faskhoudi MA; Molaei P; Sadrkhanloo M; Orouei S; Hashemi M; Bokaie S; Rashidi M; Entezari M; Zarrabi A; Hushmandi K; Mirzaei S; Gholami MH
Pathol Res Pract; 2022 May; 233():153851. PubMed ID: 35339914
[TBL] [Abstract] [Full Text] [Related]
19. Single-cell sequencing reveals myc targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy.
Wang X; Yu J; Yan J; Peng K; Zhou H
BMC Urol; 2022 Mar; 22(1):37. PubMed ID: 35305591
[TBL] [Abstract] [Full Text] [Related]
20. Development of VPC-70619, a Small-Molecule N-myc Inhibitor as a Potential Therapy for Neuroendocrine prostate cancer.
Ton AT; Foo J; Singh K; Lee J; Kalyta A; Morin H; Perez C; Ban F; Leblanc E; Lallous N; Cherkasov A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269731
[TBL] [Abstract] [Full Text] [Related]
[Next]